MannKind Quarterly Balance Sheet
NASDAQ: MNKDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
MannKind financial position
As of Jun 30, 2026, MannKind reported total assets of $732.3 million, up 77.9% from a year earlier against total liabilities of $799.5 million. Shareholders' equity was negative at -$67.2 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $52.9 million in cash and equivalents against $319.1 million of debt, a net debt position of $266.2 million.
The current ratio (current assets divided by current liabilities) was 1.72, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
MannKind balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 52.93M | 52.83M | 74.88M | 127.39M | 57.01M | 47.31M | 46.34M | 62.37M | 96.64M | 193.27M | 238.48M | 83.02M |
| Short-Term Investments | 58.20M | 81.03M | 96.46M | 132.64M | 121.98M | 134.23M | 150.92M | 189.22M | 151.12M | 107.46M | 56.62M | 58.00M |
| Receivables | 43.21M | 28.14M | 38.37M | 17.38M | 27.14M | 28.90M | 11.80M | 18.18M | 23.35M | 19.91M | 14.90M | 21.82M |
| Inventory | 44.42M | 49.17M | 35.31M | 26.97M | 28.49M | 28.89M | 27.89M | 26.66M | 24.75M | 26.44M | 28.55M | 27.12M |
| Total Current Assets | 245.71M | 251.16M | 291.58M | 358.84M | 279.03M | 273.74M | 268.31M | 327.66M | 325.94M | 383.10M | 373.39M | 225.57M |
| Property, Plant & Equipment | 85.16M | 82.55M | 82.42M | 82.65M | 82.97M | 83.78M | 85.36M | 85.34M | 85.14M | 83.62M | 84.22M | 80.41M |
| Goodwill | 67.59M | 67.59M | 67.59M | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M | 1.93M |
| Intangible Assets | 4.98M | 5.02M | 5.07M | 5.12M | 5.17M | 5.22M | 5.26M | 5.31M | 1.03M | 1.05M | 1.07M | 1.09M |
| Long-Term Investments | — | — | 5.01M | 26.23M | 22.24M | 16.68M | 5.48M | 16.80M | 13.40M | 3.73M | 7.16M | 3.27M |
| Total Assets | 732.30M | 744.40M | 792.18M | 494.64M | 411.70M | 410.14M | 393.84M | 464.20M | 443.84M | 480.88M | 475.20M | 320.33M |
| Accounts Payable | 11.04M | 16.14M | 9.03M | 7.27M | 10.26M | 5.04M | 6.79M | 6.44M | 9.56M | 7.15M | 9.58M | 16.75M |
| Total Current Liabilities | 142.90M | 134.56M | 171.03M | 109.13M | 111.83M | 115.94M | 81.84M | 72.10M | 80.01M | 99.90M | 104.13M | 96.37M |
| Long-Term Debt | 319.08M | 318.72M | 354.64M | 109.65M | 36.17M | 36.11M | 36.05M | 227.94M | 227.58M | 264.15M | 268.70M | 273.24M |
| Total Liabilities | 799.50M | 803.60M | 843.20M | 539.19M | 466.74M | 468.76M | 472.66M | 674.13M | 669.62M | 710.85M | 721.37M | 572.11M |
| Shareholders' Equity | -67.20M | -59.20M | -51.02M | -44.55M | -55.04M | -58.62M | -78.82M | -209.93M | -225.78M | -229.97M | -246.17M | -251.78M |
| Retained Earnings | -3.23B | -3.21B | -3.20B | -3.18B | -3.19B | -3.19B | -3.20B | -3.21B | -3.22B | -3.22B | -3.23B | -3.23B |
| Total Debt | 319.08M | 318.72M | 354.64M | 109.65M | 36.17M | 36.11M | 36.05M | 227.94M | 227.58M | 264.15M | 268.70M | 273.24M |
| Net Cash (Debt) | -207.96M | -184.86M | -183.29M | 150.38M | 142.82M | 145.43M | 161.21M | 23.65M | 20.18M | 36.58M | 26.40M | -132.22M |
| Shares Outstanding | 309.91M | 308.91M | 307.83M | 307.03M | 306.33M | 303.92M | 302.96M | 275.78M | 274.47M | 270.80M | 270.03M | 269.54M |
This table shows 12 quarterly periods of MannKind's balance sheet, from Q2 2026 back to Q3 2023, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow MNKD's reporting calendar. What is a balance sheet?